FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Treasury Department Investigating Apparent Taxpayer Funding of Terror Organization Under Biden and Walz

Trump says wounded National Guardsman’s mother has insisted to him that her son will survive shooting

Comer targets Walz in new House investigation, citing nearly $1B in alleged Minnesota fraud

Hakeem Jeffries Sides with Trump in Attempt to Drive a Wedge Between White House and Mike Johnson

Watch: Giants Kicker’s Bizarre Field Goal Blunder Leads to Confusion

Recordings of Brian Walshe played as prosecutors outline alleged love triangle murder

ICE Arrests Two Illegal Aliens for ‘Heinous Crimes Against Children’

Justice Department considers pursuing new indictments against James Comey, Letitia James: report

House Democrats and Republicans quietly discuss expanding personal security measures for lawmakers

Contractors renovating Washington state home discover case of live military grenades packed with TNT

Trump highlights comments by ‘Obama sycophant’ Eric Holder, continues pressing Senate GOP to nix filibuster

Pro-life center fights New Jersey attorney general’s ‘fishing expedition’ in Supreme Court battle

Chicago teachers union funneled millions to liberals while keeping members in the dark about finances

Stefanik blasts Johnson, GOP as ‘getting rolled’ by House Democrats

Florida officer shot in face during service call tied to mental health dispute; suspect killed

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”